Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Panos Fidias

Response to Treatment and Survival of Patients With Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing

Oncologist

English

Patterns of Lymphadenopathy in Thoracic Malignancies

English

Related publications

Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer

Experimental Hematology and Oncology

English

JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

Postrecurrent Survival of Patients With Non-Small-Cell Lung Cancer Undergoing a Complete Resection

Journal of Thoracic and Cardiovascular Surgery

Respiratory Medicine

Pulmonary

Cardiovascular Medicine

Surgery

Cardiology

1994

English

Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation

English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

English

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Journal of Thoracic Oncology

English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

English

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

BMC Pulmonary Medicine

Pulmonary

Respiratory Medicine

2018

English

Primary Concomitant EGFR T790M Mutation Predicted Worse Prognosis in Non-Small Cell Lung Cancer Patients

OncoTargets and Therapy

Oncology

Pharmacology

2014

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Panos Fidias

Response to Treatment and Survival of Patients With Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing

Patterns of Lymphadenopathy in Thoracic Malignancies

Related publications

Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer

JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

Postrecurrent Survival of Patients With Non-Small-Cell Lung Cancer Undergoing a Complete Resection

Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

Primary Concomitant EGFR T790M Mutation Predicted Worse Prognosis in Non-Small Cell Lung Cancer Patients